R. Flener

601 total citations
30 papers, 435 citations indexed

About

R. Flener is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, R. Flener has authored 30 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Immunology and 8 papers in Oncology. Recurrent topics in R. Flener's work include Chronic Lymphocytic Leukemia Research (8 papers), Immune Cell Function and Interaction (7 papers) and Multiple Myeloma Research and Treatments (5 papers). R. Flener is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Immune Cell Function and Interaction (7 papers) and Multiple Myeloma Research and Treatments (5 papers). R. Flener collaborates with scholars based in Austria, Belgium and Netherlands. R. Flener's co-authors include Günther Gastl, Jakob Troppmair, Heinz Ludwig, Herbert Tilg, C. Huber, Walter E. Aulitzky, K. Nachbaur, Manfred Herold, Heinz Gisslinger and Werner Linkesch and has published in prestigious journals such as The Journal of Urology, Transplantation and Cancer Immunology Immunotherapy.

In The Last Decade

R. Flener

30 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Flener Austria 13 147 134 116 107 88 30 435
Guy H. Grayson United States 5 69 0.5× 78 0.6× 115 1.0× 89 0.8× 30 0.3× 7 393
Richard P. Propp United States 11 245 1.7× 182 1.4× 223 1.9× 103 1.0× 45 0.5× 14 610
Yuet M. Ooi United States 14 323 2.2× 86 0.6× 103 0.9× 112 1.0× 28 0.3× 22 560
P Stammler Switzerland 12 355 2.4× 99 0.7× 268 2.3× 114 1.1× 20 0.2× 20 837
A Goguel France 11 99 0.7× 31 0.2× 68 0.6× 79 0.7× 29 0.3× 27 867
Roger Gooding United Kingdom 11 192 1.3× 60 0.4× 148 1.3× 137 1.3× 175 2.0× 17 586
Charles Brubaker United States 12 102 0.7× 85 0.6× 133 1.1× 111 1.0× 130 1.5× 20 523
A B Skotnicki Poland 14 103 0.7× 211 1.6× 252 2.2× 132 1.2× 146 1.7× 49 585
Siew Meng Chong Singapore 12 149 1.0× 67 0.5× 44 0.4× 171 1.6× 132 1.5× 22 649
Kishiko Nakamura Japan 13 107 0.7× 43 0.3× 123 1.1× 118 1.1× 114 1.3× 18 440

Countries citing papers authored by R. Flener

Since Specialization
Citations

This map shows the geographic impact of R. Flener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Flener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Flener more than expected).

Fields of papers citing papers by R. Flener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Flener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Flener. The network helps show where R. Flener may publish in the future.

Co-authorship network of co-authors of R. Flener

This figure shows the co-authorship network connecting the top 25 collaborators of R. Flener. A scholar is included among the top collaborators of R. Flener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Flener. R. Flener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aulitzky, Walter E., Herbert Tilg, Günther Gastl, et al.. (1991). Recombinant tumour necrosis factor alpha administered subcutaneously or intramuscularly for treatment of advanced malignant disease: a phase I trial. European Journal of Cancer and Clinical Oncology. 27(4). 462–467. 18 indexed citations
2.
Marth, Christian, Günther Gastl, Magdolna Herold, et al.. (1989). Die intraperitoneale Instillation von Interferon-gamma zur Behandlung des refraktären Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde. 49(11). 987–991. 6 indexed citations
3.
Aulitzky, Walter E., Günther Gastl, K. Nachbaur, et al.. (1989). Interferon- γ for the Treatment of Metastatic Renal Cancer: Dose-Dependent Stimulation and Downregulation of Beta-2 Microglobulin and Neopterin Responses. The Journal of Urology. 141(2). 472–472. 2 indexed citations
4.
Aulitzky, Walter E., Herbert Tilg, Manfred Herold, et al.. (1988). Enhanced Serum Levels of β-2-Microglobulin, Neopterin, and Interferon-γ in Patients Treated with Recombinant Tumor Necrosis Factor-α. Journal of Interferon Research. 8(5). 655–664. 12 indexed citations
5.
Mull, Robert, et al.. (1988). Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignancies.. PubMed. 1(1). 21–9. 8 indexed citations
6.
Seewann, H. L., Günther Gastl, Alois Lang, et al.. (1988). Interferon-alpha-2 in the treatment of idiopathic myelofibrosis. Annals of Hematology. 56(4). 161–163. 19 indexed citations
7.
Sinzinger, H, et al.. (1988). [Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].. PubMed. 100(21). 715–8. 1 indexed citations
8.
Aulitzky, Walter E., Günther Gastl, K. Nachbaur, et al.. (1987). Interferon-γ for the treatment of metastatic renal cancer: Dose-dependent stimulation and downregulation of beta2 microglobulin and neopterin responses. Immunobiology. 176(1-2). 85–95. 24 indexed citations
9.
Ludwig, Heinz, Werner Linkesch, Heinz Gisslinger, et al.. (1987). Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders. Cancer Immunology Immunotherapy. 25(3). 266–73. 42 indexed citations
10.
Gastl, Günther, et al.. (1986). Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing. Annals of Hematology. 52(5). 273–279. 19 indexed citations
11.
Woloszczuk, W., Jakob Troppmair, R. Flener, et al.. (1986). RELATIONSHIP OF INTERFERON-GAMMA AND NEOPTERIN LEVELS DURING STIMULATION WITH ALLOANTIGENS IN VIVO AND IN VITRO. Transplantation. 41(6). 716–718. 39 indexed citations
12.
Gastl, Günther, Walter E. Aulitzky, Herbert Tilg, et al.. (1986). A Biological Approach to Optimize Interferon Treatment in Hairy Cell Leukemia. Immunobiology. 172(3-5). 262–268. 15 indexed citations
13.
Gastl, Günther, H. Denz, Jakob Troppmair, et al.. (1985). Treatment with Low Dose Human Recombinant Interferon-Alpha-2-ARG Induces Complete Remission in Patients with Hairy Cell Leukemia. Oncology Research and Treatment. 8(3). 143–144. 12 indexed citations
14.
Janssen, J, Heinz Ludwig, Werner Scheithauer, et al.. (1985). Phase I Study of Recombinant Human Interferon Alpha-2C in Patients with Chemotherapy-Refractory Malignancies. Oncology. 42(1). 3–6. 5 indexed citations
15.
Kuzmits, R., E. M. Kokoschka, M. Micksche, H. Ludwig, & R. Flener. (1985). Phase II Results with Recombinant Interferons: Renal Cell Carcinoma and Malignant Melanoma. Oncology. 42(1). 26–32. 13 indexed citations
16.
Ludwig, Heinz, Agostino Cortelezzi, E Polli, et al.. (1985). Treatment with Recombinant Interferon-Alpha-2C: Multiple Myeloma and Thrombocythaemia in Myeloproliferative Diseases. Oncology. 42(1). 19–25. 16 indexed citations
17.
Huber, C., R. Flener, & Guenther Gastl. (1985). Interferon-Alpha-2 C in the Treatment of Advanced Hairy Cell Leukaemia. Oncology. 42(1). 7–9. 11 indexed citations
18.
Gastl, Günther, Christian Marth, Éva Leiter, et al.. (1985). Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.. PubMed. 45(7). 2957–61. 37 indexed citations
19.
Linkesch, Werner, Heinz Gisslinger, Heinz Ludwig, R. Flener, & H Sinzinger. (1985). [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses].. PubMed. 12(5). 123–7. 16 indexed citations
20.
Saletu, B., et al.. (1976). Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations.. PubMed. 20(6). 810–21. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guy H. Grayson Breakdown of academic impact, for papers by Richard P. Propp Breakdown of academic impact, for papers by Yuet M. Ooi Breakdown of academic impact, for papers by P Stammler Breakdown of academic impact, for papers by A Goguel Breakdown of academic impact, for papers by Roger Gooding Breakdown of academic impact, for papers by Charles Brubaker Breakdown of academic impact, for papers by A B Skotnicki Breakdown of academic impact, for papers by Siew Meng Chong Breakdown of academic impact, for papers by Kishiko Nakamura
Rankless by CCL
2026